HR8083-119 To Allow Women Greater Access To Safe And Effective Oral Contraceptive Drugs Intended For Routine Use, And To Direct The Comptroller General Of The United States To Conduct A Study On Federal Funding Of Contraceptive Methods.

Sponsor: Hinson, Ashley, IA

Representative for undefined's undefinedth district. undefined.

A bill summary has not yet been created for this bill.

Likes

Dislikes


Bill Timeline

  1. Introduced

    Introduced in House

  2. Referred

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Natural Resources, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


Comments


Committees

ActivityCommittee
Referred ToHouse Armed Services Committee
Referred ToHouse Natural Resources Committee
Referred ToHouse Ways and Means Committee
Referred ToHouse Energy and Commerce Committee

This bill's main subject is: Health

Source:Congress.gov

Bill Cosponsors

NameSponsored AtStateTitle
Ciscomani, Juan2026-03-25AZRep.
Miller-Meeks, Mariannette2026-03-25IARep.
Nunn, Zachary2026-03-25IARep.

Related Legislation

Browse all bills

Frequently Asked Questions

What is HR8083-119 about?

To allow women greater access to safe and effective oral contraceptive drugs intended for routine use, and to direct the Comptroller General of the United States to conduct a study on Federal funding of contraceptive methods.

Who sponsored HR8083-119?

Sponsored by Hinson, Ashley.

When was HR8083-119 introduced?

HR8083-119 was introduced on March 25, 2026.

What is the current status of HR8083-119?

Current status: REFERRED.